Pages that link to "Q39245939"

The following pages link to Alterations in protein synthetic capability of nerve cells in Alzheimer's disease (Q39245939):

Displaying 27 items.

• Two distinct secretory ribonucleases from human cerebrum: purification, characterization and relationships to other ribonucleases (Q24528628) (← links)
• Metabolism and possible health effects of aluminum (Q28389111) (← links)
• Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex (Q33551321) (← links)
• Alzheimer's disease: a correlative study (Q33621991) (← links)
• The noradrenergic system in Alzheimer and multi-infarct dementias (Q33755706) (← links)
• Brain aging and Alzheimer's disease; use it or lose it. (Q34997783) (← links)
• Entorhinal verrucae geometry is coincident and correlates with Alzheimer's lesions: a combined neuropathology and high-resolution ex vivo MRI analysis (Q35755478) (← links)
• A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules (Q36190490) (← links)
• Preparation of a recombinant cDNA library from poly(A ) RNA of the Alzheimer brain. Identification and characterization of a cDNA copy encoding a glial-specific protein (Q36452038) (← links)
• Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons (Q37221892) (← links)
• Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease (Q37457163) (← links)
• DNA damage and chronic neuronal degenerations (Q40117458) (← links)
• Changes in the number of neurons in the mesencephalic and motor nuclei of the trigeminal nerve in the ageing mouse brain (Q41771294) (← links)
• Nerve cell protein metabolism and degenerative disease (Q42448524) (← links)
• Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease (Q43872614) (← links)
• Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease (Q45292608) (← links)
• Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease (Q47728639) (← links)
• The postmortem Alzheimer brain is a source of structurally and functionally intact astrocytic messenger RNA (Q48103149) (← links)
• Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease (Q48168982) (← links)
• RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. (Q48270446) (← links)
• Decreased CSF acetylcholinesterase activity in Alzheimer's disease (Q48759984) (← links)
• Cytophotometric assessment of Feulgen-DNA and coomassie-total cell protein in adrenocortical fasciculata cells of noise-exposed wister rats (Q50800874) (← links)
• Genetic expression of amyloid and glial-specific protein in the Alzheimer brain. (Q53192709) (← links)
• Distribution and expression of the alpha-tubulin mRNA in the hippocampus and the temporal cortex in Alzheimer's disease. (Q53310562) (← links)
• Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type. (Q53322786) (← links)
• Tau drives translational selectivity by interacting with ribosomal proteins (Q64273568) (← links)
• Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment (Q91894190) (← links)